Cargando…

Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review

Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaramillo, Arturo P, Awosusi, Babatope L, Ayyub, Javaria, Dabhi, Karan Nareshbhai, Gohil, Namra V, Tanveer, Nida, Hussein, Sally, Pingili, Shravya, Makkena, Vijaya Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439665/
https://www.ncbi.nlm.nih.gov/pubmed/37602044
http://dx.doi.org/10.7759/cureus.42120
_version_ 1785093000693547008
author Jaramillo, Arturo P
Awosusi, Babatope L
Ayyub, Javaria
Dabhi, Karan Nareshbhai
Gohil, Namra V
Tanveer, Nida
Hussein, Sally
Pingili, Shravya
Makkena, Vijaya Krishna
author_facet Jaramillo, Arturo P
Awosusi, Babatope L
Ayyub, Javaria
Dabhi, Karan Nareshbhai
Gohil, Namra V
Tanveer, Nida
Hussein, Sally
Pingili, Shravya
Makkena, Vijaya Krishna
author_sort Jaramillo, Arturo P
collection PubMed
description Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota transplantation (FMT) has many benefits in the treatment of inflammatory bowel disease (IBD) by restoring intestinal homeostasis and reducing clinical symptoms. In mildly symptomatic patients with UC, an FMT treatment combined with an anti-inflammatory diet can produce remission, which would then be followed by a diet that maintained the anti-inflammatory effects. The efficacy of FMT consists of preventing flares or the consequences of IBD. As a result, we must emphasize that more investigation should be done before developing a therapeutic procedure for FMT in IBD and its associated consequences.
format Online
Article
Text
id pubmed-10439665
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104396652023-08-20 Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review Jaramillo, Arturo P Awosusi, Babatope L Ayyub, Javaria Dabhi, Karan Nareshbhai Gohil, Namra V Tanveer, Nida Hussein, Sally Pingili, Shravya Makkena, Vijaya Krishna Cureus Internal Medicine Cronh’s disease and ulcerative colitis (UC) are diseases with unknown etiologies that cause ongoing inflammation in the gastrointestinal system. Chron's disease causes immunological dysregulation, and UC causes intestinal harm due to immune reactions. According to our study, fecal microbiota transplantation (FMT) has many benefits in the treatment of inflammatory bowel disease (IBD) by restoring intestinal homeostasis and reducing clinical symptoms. In mildly symptomatic patients with UC, an FMT treatment combined with an anti-inflammatory diet can produce remission, which would then be followed by a diet that maintained the anti-inflammatory effects. The efficacy of FMT consists of preventing flares or the consequences of IBD. As a result, we must emphasize that more investigation should be done before developing a therapeutic procedure for FMT in IBD and its associated consequences. Cureus 2023-07-19 /pmc/articles/PMC10439665/ /pubmed/37602044 http://dx.doi.org/10.7759/cureus.42120 Text en Copyright © 2023, Jaramillo et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Jaramillo, Arturo P
Awosusi, Babatope L
Ayyub, Javaria
Dabhi, Karan Nareshbhai
Gohil, Namra V
Tanveer, Nida
Hussein, Sally
Pingili, Shravya
Makkena, Vijaya Krishna
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title_full Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title_fullStr Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title_full_unstemmed Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title_short Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
title_sort effectiveness of fecal microbiota transplantation treatment in patients with recurrent clostridium difficile infection, ulcerative colitis, and crohn’s disease: a systematic review
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439665/
https://www.ncbi.nlm.nih.gov/pubmed/37602044
http://dx.doi.org/10.7759/cureus.42120
work_keys_str_mv AT jaramilloarturop effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT awosusibabatopel effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT ayyubjavaria effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT dabhikarannareshbhai effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT gohilnamrav effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT tanveernida effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT husseinsally effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT pingilishravya effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview
AT makkenavijayakrishna effectivenessoffecalmicrobiotatransplantationtreatmentinpatientswithrecurrentclostridiumdifficileinfectionulcerativecolitisandcrohnsdiseaseasystematicreview